540 related articles for article (PubMed ID: 20554718)
21. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
22. Diabetes and cancer: a 2013 synopsis.
Buysschaert M; Sadikot S
Diabetes Metab Syndr; 2013; 7(4):247-50. PubMed ID: 24290094
[TBL] [Abstract][Full Text] [Related]
23. Why insulin sensitizers but not secretagogues should be retained when initiating insulin in type 2 diabetes.
Raskin P
Diabetes Metab Res Rev; 2008; 24(1):3-13. PubMed ID: 17968971
[TBL] [Abstract][Full Text] [Related]
24. [Controversial aspects regarding metformin in type 2 diabetic patient: reduction of late complications in early, single drug administration; increased risk of death in later administration in combination with sulfonylurea compounds].
Ritzmann P
Praxis (Bern 1994); 1999 Aug; 88(33):1330-1. PubMed ID: 10483287
[No Abstract] [Full Text] [Related]
25. Insulin analogues and cancer risk: cause for concern or cause célèbre?
Pollak M; Russell-Jones D
Int J Clin Pract; 2010 Apr; 64(5):628-36. PubMed ID: 20201993
[TBL] [Abstract][Full Text] [Related]
26. Balancing risk and benefit with oral hypoglycemic drugs.
Hamnvik OP; McMahon GT
Mt Sinai J Med; 2009 Jun; 76(3):234-43. PubMed ID: 19421967
[TBL] [Abstract][Full Text] [Related]
27. Prospective study of hyperglycemia and cancer risk: response to Stattin et al.
Bowker SL; Johnson JA
Diabetes Care; 2007 Jul; 30(7):e77; author reply e78. PubMed ID: 17596500
[No Abstract] [Full Text] [Related]
28. Diabetes and pancreatic cancer.
Cui Y; Andersen DK
Endocr Relat Cancer; 2012 Oct; 19(5):F9-F26. PubMed ID: 22843556
[TBL] [Abstract][Full Text] [Related]
29. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
Gallagher EJ; LeRoith D
Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):485-94. PubMed ID: 23974779
[TBL] [Abstract][Full Text] [Related]
30. [Diabetes and cancer: an injurious association].
Gariani K; Tran C; Philippe J
Rev Med Suisse; 2010 Jun; 6(252):1193-4, 1196-8. PubMed ID: 20614754
[TBL] [Abstract][Full Text] [Related]
31. Diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly.
Berlie HD; Garwood CL
Ann Pharmacother; 2010 Apr; 44(4):712-7. PubMed ID: 20215495
[TBL] [Abstract][Full Text] [Related]
32. Insulin, insulin analogues and cancer: no cause for panic.
Thomson GA
Int J Clin Pract; 2010 Apr; 64(5):525-7. PubMed ID: 20456201
[No Abstract] [Full Text] [Related]
33. Addressing different biases in analysing drug use on cancer risk in diabetes in non-clinical trial settings--what, why and how?
Yang XL; Ma RC; So WY; Kong AP; Xu G; Chan JC
Diabetes Obes Metab; 2012 Jul; 14(7):579-85. PubMed ID: 22171706
[TBL] [Abstract][Full Text] [Related]
34. [Current evidence-based medicine for early intervention in diabetes].
Sano H; Tajima N
Nihon Rinsho; 2008 Oct; 66(10):2027-32. PubMed ID: 18939508
[TBL] [Abstract][Full Text] [Related]
35. Diabetes and cancer: placing the association in perspective.
Andersen DK
Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):81-6. PubMed ID: 23422245
[TBL] [Abstract][Full Text] [Related]
36. Insulin therapy in diabetes and cancer risk: current understanding and implications for future study: proceedings from a meeting of a European Insulin Safety Consensus Panel, convened and sponsored by Novo Nordisk, held Tuesday October 5, 2010 at The Radisson Edwardian Heathrow Hotel, Hayes, Middlesex, UK.
Gough SC; Belda-Iniesta C; Poole C; Weber M; Russell-Jones D; Hansen BF; Mannucci E; Tuomilehto J
Adv Ther; 2011 Sep; 28 Suppl 5():1-18. PubMed ID: 21863297
[TBL] [Abstract][Full Text] [Related]
37. Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260.
Simon D; Balkau B
Diabetes; 2010 Nov; 59(11):e25. PubMed ID: 20980467
[No Abstract] [Full Text] [Related]
38. Hyperglycaemia in acute coronary syndromes: summary of NICE guidance.
Senthinathan A; Kelly V; Dzingina M; Jones D; Baker M; Longson D;
BMJ; 2011 Oct; 343():d6646. PubMed ID: 22031910
[No Abstract] [Full Text] [Related]
39. [Antidiabetic drugs and their effect on bone].
Jackuliak P; Kužma M; Payer J
Vnitr Lek; 2017; 63(9):609-616. PubMed ID: 29120659
[TBL] [Abstract][Full Text] [Related]
40. Type 2 diabetes and cancer: should we prefer antihyperglycaemic treatments without unnecessarily increasing insulin levels?
Matthaei S
Diab Vasc Dis Res; 2014 Nov; 11(6):370. PubMed ID: 25249176
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
